[1]
|
Fraser, S.D.S. and Roderick, P.J. (2019) Kidney Disease in the Global Burden of Disease Study 2017. Nature Reviews Nephrology, 15, 193-194. https://doi.org/10.1038/s41581-019-0120-0
|
[2]
|
Toyoda, K. (2015) Cerebral Small Vessel Disease and Chronic Kidney Disease. Journal of Stroke, 17, 31-37.
https://doi.org/10.5853/jos.2015.17.1.31
|
[3]
|
Packham, D.K., Alves, T.P., Dwyer, J.P., et al. (2012) Relative Inci-dence of ESRD versus Cardiovascular Mortality in Proteinuric Type 2 Diabetes and Nephropathy: Results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) Database. American Journal of Kidney Diseases, 59, 75-83.
https://doi.org/10.1053/j.ajkd.2011.09.017
|
[4]
|
Vashistha, V., Lee, M., Wu, Y.L., et al. (2016) Low Glomerular Filtration Rate and Risk of Myocardial Infarction: A Systematic Review and Meta-Analysis. International Journal of Cardiology, 223, 401-409.
https://doi.org/10.1016/j.ijcard.2016.07.175
|
[5]
|
Kelly, D. and Rothwell, P.M. (2020) Disentangling the Multiple Links between Renal Dysfunction and Cerebrovascular Disease. Journal of Neurology, Neurosurgery & Psychiatry, 91, 88-97. https://doi.org/10.1136/jnnp-2019-320526
|
[6]
|
Dad, T. and Weiner, D.E. (2015) Stroke and Chronic Kid-ney Disease: Epidemiology, Pathogenesis, and Management across Kidney Disease Stages. Seminars in Nephrology, 35, 311-322. https://doi.org/10.1016/j.semnephrol.2015.06.003
|
[7]
|
Seliger, S.L., Gillen, D.L., Longstreth, W.T., et al. (2003) Elevated Risk of Stroke among Patients with End-Stage Renal Disease. Kidney International, 64, 603-609. https://doi.org/10.1046/j.1523-1755.2003.00101.x
|
[8]
|
Grams, M.E., Yang, W., Rebholz, C.M., et al. (2017) Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases, 70, 337-346.
https://doi.org/10.1053/j.ajkd.2017.01.050
|
[9]
|
Weiner, D.E., Tighiouart, H., Stark, P.C., et al. (2004) Kidney Disease as a Risk Factor for Recurrent Cardiovascular Disease and Mortality. American Journal of Kidney Diseases, 44, 198-206. https://doi.org/10.1053/j.ajkd.2004.04.024
|
[10]
|
Toyoda, K. and Ninomiya T. (2014) Stroke and Cerebro-vascular Diseases in Patients with Chronic Kidney Disease. The Lancet Neurology, 13, 823-833. https://doi.org/10.1016/S1474-4422(14)70026-2
|
[11]
|
Wyld, M. and Webster, A.C. (2021) Chronic Kidney Disease Is a Risk Factor for Stroke. Journal of Stroke and Cerebrovascular Diseases, 30, Article ID: 105730. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105730
|
[12]
|
Weiner, D.E., Tighiouart, H., Amin, M.G., et al. (2004) Chronic Kidney Disease As a Risk Factor for Cardiovascular Disease and All-Cause Mortality: A Pooled Analy-sis of Community-Based Studies. Journal of the American Society of Nephrology, 15, 1307-1315. https://doi.org/10.1097/01.ASN.0000123691.46138.E2
|
[13]
|
Lee, M., Saver, J.L., Chang, K.H., et al. (2010) Low Glomerular Filtration Rate and Risk of Stroke: Meta-Analysis. BMJ, 341, Article No. C4249. https://doi.org/10.1136/bmj.c4249
|
[14]
|
Masson, P., Webster, A.C., Hong, M., et al. (2015) Chronic Kidney Dis-ease and the Risk of Stroke: A Systematic Review and Meta-Analysis. Nephrology Dialysis Transplantation, 30, 1162-1169. https://doi.org/10.1093/ndt/gfv009
|
[15]
|
Oh, C.M., Park, S.K., Jung, J.Y., et al. (2021) Reduced Glo-merular Filtration Rate and Risk of Stroke: A Nationwide Cohort Study in South Korea. Journal of Atherosclerosis and Thrombosis, 28, 928-941.
https://doi.org/10.5551/jat.56143
|
[16]
|
Ninomiya, T., Perkovic, V., Verdon, C., et al. (2009) Proteinuria and Stroke: A Meta-Analysis of Cohort Studies. American Journal of Kidney Diseases, 53, 417-425. https://doi.org/10.1053/j.ajkd.2008.08.032
|
[17]
|
Kelly, D.M. and Rothwell, P.M. (2020) Proteinuria as an Inde-pendent Predictor of Stroke: Systematic Review and Meta-analysis. International Journal of Stroke, 15, 29-38. https://doi.org/10.1177/1747493019895206
|
[18]
|
Lee, M., Saver, J.L., Chang, K.-H., et al. (2010) Level of Albu-minuria and Risk of Stroke: Systematic Review and Meta-Analysis. Cerebrovascular Diseases, 30, 464-469. https://doi.org/10.1159/000317069
|
[19]
|
Gutiérrez, O.M.J.S., Muntner, P., Rizk, D.V., McClellan, W.M., Safford, M.M., et al. (2012) Racial Differences in Albuminuria, Kidney Function, and Risk of Stroke. Neurology, 79, 1686-1692.
https://doi.org/10.1212/WNL.0b013e31826e9af8
|
[20]
|
Iseki, K., Kinjo, K., Kimura, Y., Osawa, A. and Fukiyama, K. (1993) Evidence for High Risk of Cerebral Hemorrhage in Chronic Dialysis Patients. Kidney International, 44, 1086-1090. https://doi.org/10.1038/ki.1993.352
|
[21]
|
Murray, A.M., Seliger, S., Lakshminarayan, K., et al. (2013) Incidence of Stroke before and after Dialysis Initiation in Older Patients. Journal of the American Society of Nephrology, 24, 1166-1173.
https://doi.org/10.1681/ASN.2012080841
|
[22]
|
Collins, A.J., Foley, R.N., Chavers, B., et al. (2012) United States Renal Data System 2011 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. American Journal of Kidney Diseases, 59, Article No. A7. https://doi.org/10.1053/j.ajkd.2011.11.015
|
[23]
|
Kumai, Y., Kamouchi, M., Hata, J., et al. (2012) Proteinuria and Clinical Outcomes after Ischemic Stroke. Neurology, 78, 1909-1915. https://doi.org/10.1212/WNL.0b013e318259e110
|
[24]
|
El Husseini, N., Fonarow, G.C., Smith, E.E., et al. (2017) Renal Dysfunction Is Associated with Poststroke Discharge Disposition and In-Hospital Mortality: Findings from Get with the Guidelines-Stroke. Stroke, 48, 327-334.
https://doi.org/10.1161/STROKEAHA.116.014601
|
[25]
|
Yeh, S.J., Jeng, J.S., Tang, S.C., et al. (2015) Low Esti-mated Glomerular Filtration Rate Is Associated with Poor Outcomes in Patients Who Suffered a Large Artery Athero-sclerosis Stroke. Atherosclerosis, 239, 328-334.
https://doi.org/10.1016/j.atherosclerosis.2015.01.038
|
[26]
|
Molshatzki, N., Orion, D., Tsabari, R., et al. (2011) Chronic Kidney Disease in Patients with Acute Intracerebral Hemorrhage: Association with Large Hematoma Volume and Poor Outcome. Cerebrovascular Diseases, 31, 271-277.
https://doi.org/10.1159/000322155
|
[27]
|
Ito, S., Nagasawa, T., Abe, M., et al. (2009) Strain Vessel Hypothesis: A Viewpoint for Linkage of Albuminuria and Cerebro-Cardiovascular Risk. Hypertension Research, 32, 115-121. https://doi.org/10.1038/hr.2008.27
|
[28]
|
Bernbaum, M., Menon, B.K., Fick, G., et al. (2015) Reduced Blood Flow in Normal White Matter Predicts Development of Leukoaraiosis. Journal of Cerebral Blood Flow & Metabolism, 35, 1610-1615.
https://doi.org/10.1038/jcbfm.2015.92
|
[29]
|
Deramecourt, V., Slade, J.Y., Oakley, A.E., et al. (2012) Staging and Natural History of Cerebrovascular Pathology in Dementia. Neurology, 78, 1043-1050. https://doi.org/10.1212/WNL.0b013e31824e8e7f
|
[30]
|
Nagasawa, T., Mori, T., Ohsaki, Y., et al. (2012) Albuminu-ria Indicates the Pressure-associated Injury of Juxtamedullary Nephrons and Cerebral Strain Vessels in Spontaneously Hypertensive Stroke-Prone Rats. Hypertension Research, 35, 1024-1031. https://doi.org/10.1038/hr.2012.112
|
[31]
|
Kanamaru, T., Suda, S., Muraga, K., et al. (2017) Albuminuria Predicts Early Neurological Deterioration in Patients with Acute Ischemic Stroke. Journal of the Neurological Sciences, 372, 417-420.
https://doi.org/10.1016/j.jns.2016.11.007
|
[32]
|
Akchurin, O.M. and Kaskel, F. (2015) Update on Inflammation in Chronic Kidney Disease. Blood Purification, 39, 84-92. https://doi.org/10.1159/000368940
|
[33]
|
Mihai, S., Codrici, E., Popescu, I.D., et al. (2016) Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease. Disease Markers, 2016, Article ID: 3185232. https://doi.org/10.1155/2016/3185232
|
[34]
|
Amdur, R.L., Feldman, H.I., Gupta, J., et al. (2016) Inflammation and Progression of CKD: The CRIC Study. Clinical Journal of the American Society of Nephrology, 11, 1546-1556. https://doi.org/10.2215/CJN.13121215
|
[35]
|
Alves, F.C., Sun, J., Qureshi, A.R., et al. (2018) the Higher Mortality Associated with Low Serum Albumin Is Dependent on Systemic Inflammation in End-stage Kidney Disease. PLoS ONE, 13, Article ID: e0190410.
https://doi.org/10.1371/journal.pone.0190410
|
[36]
|
Assem, M., Lando, M., Grissi, M., et al. (2018) the Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders. Toxins, 10, Article No. 303. https://doi.org/10.3390/toxins10070303
|
[37]
|
Yu, M., Kim, Y.J. and Kang, D.H. (2011) Indoxyl Sulfate-induced Endothelial Dysfunction in Patients with Chronic Kidney Disease via an Induction of Oxidative Stress. Clinical Journal of the American Society of Nephrology, 6, 30-39.
https://doi.org/10.2215/CJN.05340610
|
[38]
|
Taddei, S., Virdis, A., Ghiadoni, L., et al. (2001) Endothelial Dysfunc-tion in Hypertension. Journal of Cardiovascular Pharmacology, 38, S11-S14. https://doi.org/10.1097/00005344-200111002-00004
|
[39]
|
Virdis, A., Ghiadoni, L., Cardinal, H., Favilla, S., Du-ranti, P., Birindelli, R., Magagna, A., Bernini, G., Salvetti, G., Taddei, S. and Salvetti, A. (2001) Mechanisms Responsi-ble for Endothelial Dysfunction Induced by Fasting Hyperhomocystinemia in Normotensive Subjects and Patients with Essential Hypertension. Journal of the American College of Cardiology, 38, 1106-1115. https://doi.org/10.1016/S0735-1097(01)01492-9
|
[40]
|
Ma, Y., Zhou, L., Dong, J., et al. (2015) Arterial Stiffness and Increased Cardiovascular Risk in Chronic Kidney Disease. International Urology and Nephrology, 47, 1157-1164. https://doi.org/10.1007/s11255-015-1009-x
|
[41]
|
Choi, H.Y., Park, S.K., Yun, G.Y., et al. (2016) Glycated Albu-min Is Independently Associated with Arterial Stiffness in Non-Diabetic Chronic Kidney Disease Patients. Medicine, 95, Article No. e3362.
https://doi.org/10.1097/MD.0000000000003362
|
[42]
|
Jing, W., Jabbari, B. and Vaziri, N.D. (2018) Uremia Induc-es Upregulation of Cerebral Tissue Oxidative/Inflammatory Cascade, Down-Regulation of Nrf2 Pathway and Disruption of Blood Brain Barrier. American Journal of Translational Research, 10, 2137-2147.
|
[43]
|
Kusano, E. (2011) Mecha-nism by Which Chronic Kidney Disease Causes Cardiovascular Disease and the Measures to Manage This Phenomenon. Clinical and Experimental Nephrology, 15, 627-633.
https://doi.org/10.1007/s10157-011-0461-x
|
[44]
|
Moe, S.M. (2012) Klotho: A Master Regulator of Cardiovascular Disease? Circulation, 125, 2181-2183.
https://doi.org/10.1161/CIRCULATIONAHA.112.104828
|
[45]
|
Yan, J., Li, L., Zhang, M., Cai, H. and Ni, Z. (2018) Circulating Bone-Specific Alkaline Phosphatase and Abdominal Aortic Calcification in Maintenance Hemodialy-sis Patients. Biomarkers in Medicine, 12, 1231-1239.
https://doi.org/10.2217/bmm-2018-0089
|
[46]
|
Chue, C.D., Townend, J.N., Steeds, R.P., et al. (2010) Arterial Stiff-ness in Chronic Kidney Disease: Causes and Consequences. Heart, 96, 817-823. https://doi.org/10.1136/hrt.2009.184879
|
[47]
|
Bugnicourt, J.M., Chillon, J.M., Massy, Z.A., et al. (2009) High Prevalence of Intracranial Artery Calcification in Stroke Patients with CKD: A Retrospective Study. Clinical Journal of the American Society of Nephrology, 4, 284-290.
https://doi.org/10.2215/CJN.02140508
|
[48]
|
Hruska, K.A., Mathew, S., Lund, R., et al. (2008) Hyperphosphatemia of Chronic Kidney Disease. Kidney International, 74, 148-157. https://doi.org/10.1038/ki.2008.130
|
[49]
|
Lau, W.L. and Ix, J.H. (2013) Clinical Detection, Risk Factors, and Cardiovascular Consequences of Medial Arterial Calcification: A Pattern of Vascular Injury Associated with Aberrant Mineral Metabolism. Seminars in Nephrology, 33, 93-105. https://doi.org/10.1016/j.semnephrol.2012.12.011
|
[50]
|
Lau, W.L., Huisa, B.N. and Fisher, M. (2017) The Cere-brovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms. Translational Stroke Research, 8, 67-76. https://doi.org/10.1007/s12975-016-0499-x
|
[51]
|
Chen, T., Mao, H., Chen, C., et al. (2015) The Role and Mechanism of Alpha-Klotho in the Calcification of Rat Aortic Vascular Smooth Muscle Cells. BioMed Research Interna-tional, 2015, Article ID: 194362.
https://doi.org/10.1155/2015/194362
|
[52]
|
Hojs Fabjan, T. and Hojs, R. (2014) Stroke and Renal Dysfunction. Eu-ropean Journal of Internal Medicin, 25, 18-24.
https://doi.org/10.1016/j.ejim.2013.08.710
|
[53]
|
Desbien, A.M., Chonchol, M., Gnahn, H., et al. (2008) Kidney Function and Progression of Carotid Intima-Media Thickness in a Community Study. American Journal of Kidney Dis-eases, 51, 584-593.
https://doi.org/10.1053/j.ajkd.2007.11.026
|
[54]
|
Gu, X., Fang, X., Hua, Y., et al. (2016) Association between Kid-ney Dysfunction and Carotid Atherosclerosis in Community-Based Older Adults in China. Angiology, 67, 252-258. https://doi.org/10.1177/0003319715586505
|
[55]
|
Kajitani, N., Uchida, H.A., Suminoe, I., et al. (2018) Chronic Kidney Disease Is Associated with Carotid Atherosclerosis and Symptomatic Ischaemic Stroke. Journal of International Medical Research, 46, 3873-3883.
https://doi.org/10.1177/0300060518781619
|
[56]
|
Song, X., Li, J., Hua, Y., et al. (2020) Chronic Kidney Disease Is Associated with Intracranial Artery Stenosis Distribution in the Middle-Aged and Elderly Population. Journal of Athero-sclerosis and Thrombosis, 27, 245-254.
https://doi.org/10.5551/jat.49569
|
[57]
|
Ghoshal, S. and Freedman, B.I. (2019) Mechanisms of Stroke in Patients with Chronic Kidney Disease. American Journal of Nephrology, 50, 229-239. https://doi.org/10.1159/000502446
|
[58]
|
Thompson, C.S. and Hakim, A.M. (2009) Living Beyond Our Physiolog-ical Means: Small Vessel Disease of the Brain Is an Expression of a Systemic Failure in Arteriolar Function: A Unifying Hypothesis. Stroke, 40, e322-e330.
https://doi.org/10.1161/STROKEAHA.108.542266
|
[59]
|
Armstead, W.M. (2016) Cerebral Blood Flow Autoregu-lation and Dysautoregulation. Anesthesiology Clinics, 34, 465-477. https://doi.org/10.1016/j.anclin.2016.04.002
|
[60]
|
Carlstrom, M., Wilcox, C.S. and Arendshorst, W.J. (2015) Renal Autoregulation in Health and Disease. Physiological Reviews, 95, 405-511. https://doi.org/10.1152/physrev.00042.2012
|
[61]
|
Castro, P., Azevedo, E., Rocha, I., et al. (2018) Chronic Kidney Disease and Poor Outcomes in Ischemic Stroke: Is Impaired Cerebral Autoregulation the Missing Link? BMC Neurology, 18, Article No. 21.
https://doi.org/10.1186/s12883-018-1025-4
|
[62]
|
Polinder-Bos, H.A., Garcia, D.V., Kuipers, J., et al. (2018) He-modialysis Induces an Acute Decline in Cerebral Blood Flow in Elderly Patients. Journal of the American Society of Nephrology, 29, 1317-1325.
https://doi.org/10.1681/ASN.2017101088
|
[63]
|
Graus, F., Escudero, D., Oleaga, L., et al. (2018) Syndrome and Outcome of Antibody-Negative Limbic Encephalitis. European Journal of Neurology, 25, 1011-1016. https://doi.org/10.1111/ene.13661
|
[64]
|
Shang, W., Li, L., Huang, S., et al. (2016) Chronic Kidney Disease and the Risk of New-Onset Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies. PLoS ONE, 11, Article ID: e0155581.
https://doi.org/10.1371/journal.pone.0155581
|
[65]
|
Boriani, G., Savelieva, I., Dan, G.A., et al. (2015) Chronic Kid-ney Disease in Patients with Cardiac Rhythm Disturbances Or Implantable Electrical Devices: Clinical Significance and Implications for Decision Making—A Position Paper of the European Heart Rhythm Association Endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. EP Europace, 17, 1169-1196. https://doi.org/10.1093/europace/euv202
|
[66]
|
Mehta, R., Cai, X., Lee, J., et al. (2016) Association of Fibroblast Growth Factor 23 with Atrial Fibrillation in Chronic Kidney Disease, from the Chronic Renal Insufficiency Cohort Study. JAMA Cardiology, 1, 548-556.
https://doi.org/10.1001/jamacardio.2016.1445
|
[67]
|
Yau, J.W., Teoh, H. and Verma, S. (2015) Endothelial Cell Control of Thrombosis. BMC Cardiovascular Disorders, 15, Article No. 130. https://doi.org/10.1186/s12872-015-0124-z
|
[68]
|
Naganuma, T., Takemoto, Y., Shoji, T., et al. (2015) Cerebral Mi-crobleeds Predict Intracerebral Hemorrhage in Hemodialysis Patients. Stroke, 46, 2107-2112. https://doi.org/10.1161/STROKEAHA.115.009324
|
[69]
|
Lau, W.L., Nunes, A.C.F., Vasilevko, V., et al. (2020) Chronic Kidney Disease Increases Cerebral Microbleeds in Mouse and Man. Translational Stroke Research, 11, 122-134. https://doi.org/10.1007/s12975-019-00698-8
|
[70]
|
Major, R.W., Cheung, C.K., Gray, L.J., et al. (2015) Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis. Clinical Journal of the American Society of Nephrology, 10, 732-739.
https://doi.org/10.2215/CJN.07460714
|
[71]
|
Pavlou, E.G., Georgatzakou, H.T., Fortis, S.P., et al. (2021) Coagula-tion Abnormalities in Renal Pathology of Chronic Kidney Disease: The Interplay between Blood Cells and Soluble Fac-tors. Biomolecules, 11, Article No. 1309.
https://doi.org/10.3390/biom11091309
|
[72]
|
Abdelmaguid, A., Roberts, L.N., Tugores, L., et al. (2022) Evaluation of Novel Coagulation and Platelet Function Assays in Patients with Chronic Kidney Disease. Journal of Thrombosis and Haemostasis, 20, 845-856.
https://doi.org/10.1111/jth.15653
|
[73]
|
Ovbiagele, B., Bath, P.M., Cotton, D., et al. (2013) Low Glomerular Filtra-tion Rate, Recurrent Stroke Risk, and Effect of Renin-angiotensin System Modulation. Stroke, 44, 3223-3225. https://doi.org/10.1161/STROKEAHA.113.002463
|
[74]
|
Sarfo, F.S., Mobula, L.M., Sarfo-Kantanka, O., et al. (2019) Estimated Glomerular Filtration Rate Predicts Incident Stroke among Ghanaians with Diabetes and Hypertension. Journal of the Neurological Sciences, 396, 140-147.
https://doi.org/10.1016/j.jns.2018.11.017
|
[75]
|
Muntner, P., Judd, S.E., McClellan, W., et al. (2012) Incidence of Stroke Symptoms among Adults with Chronic Kidney Disease: Results from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Nephrology Dialysis Transplantation, 27, 166-173. https://doi.org/10.1093/ndt/gfr218
|
[76]
|
Cornelissen, A., Fuller, D.T., Fernandez, R., et al. (2021) APOL1 Genetic Variants Are Associated with Increased Risk of Coronary Atherosclerotic Plaque Rupture in the Black Population. Arte-riosclerosis, Thrombosis, and Vascular Biology, 41, 2201-2214. https://doi.org/10.1161/ATVBAHA.120.315788
|
[77]
|
Chen, T.K., Fitzpatrick, J., Winkler, C.A., et al. (2021) APOL1 Risk Variants and Subclinical Cardiovascular Disease in Incident Hemodialysis Patients. Kidney International Reports, 6, 333-341. https://doi.org/10.1016/j.ekir.2020.11.006
|
[78]
|
Gutierrez, O.M., Irvin, M.R., Chaudhary, N.S., et al. (2018) APOL1 Nephropathy Risk Variants and Incident Cardiovascular Disease Events in Community-Dwelling Black Adults. Circulation: Genomic and Precision Medicine, 11, Article No. e002098. https://doi.org/10.1161/CIRCGEN.117.002098
|
[79]
|
Jabbari, B. and Vaziri, N.D. (2018) The Nature, Consequenc-es, and Management of Neurological Disorders in Chronic Kidney Disease. Hemodialysis International, 22, 150-160. https://doi.org/10.1111/hdi.12587
|
[80]
|
Lau, W.L. (2021) Controversies: Stroke Prevention in Chronic Kidney Dis-ease. Journal of Stroke and Cerebrovascular Diseases, 30, Article ID: 105679. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105679
|
[81]
|
Drechsler, C., Kalim, S., Wenger, J.B., et al. (2015) Protein Carbamylation Is Associated with Heart Failure and Mortality in Diabetic Patients with End-Stage Renal Disease. Kidney International, 87, 1201-1208.
https://doi.org/10.1038/ki.2014.429
|
[82]
|
Chelluboina, B. and Vemuganti, R. (2019) Chronic Kidney Disease in the Pathogenesis of Acute Ischemic Stroke. Journal of Cerebral Blood Flow & Metabolism, 39, 1893-1905. https://doi.org/10.1177/0271678X19866733
|
[83]
|
Jung, J.M., Kim, H.J., Ahn, H., et al. (2015) Chronic Kidney Disease and Intravenous Thrombolysis in Acute Stroke: A Systematic Review and Meta-Analysis. Journal of the Neu-rological Sciences, 358, 345-350.
https://doi.org/10.1016/j.jns.2015.09.353
|
[84]
|
Manners, J., Steinberg, A. and Shutter, L. (2017) Early Management of Acute Cerebrovascular Accident. Current Opinion in Critical Care, 23, 556-560. https://doi.org/10.1097/MCC.0000000000000462
|
[85]
|
Tonelli, M., Karumanchi, S.A. and Thadhani, R. (2016) Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease. Circulation, 133, 518-536. https://doi.org/10.1161/CIRCULATIONAHA.115.018713
|